ERWIN RONALD BOCH;JEFF BAXTER;DAVID E. ANDERSON;VARIATION BIOTECHNOLOGIES INC;ANDREI OGREL
发明人:
DAVID E. ANDERSON,ANDREI OGREL,ERWIN RONALD BOCH,JEFF BAXTER
申请号：
IL22402212
公开号：
IL224022A
申请日:
2012.12.30
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The present disclosure provides compositions and methods useful for treating influenza. As described herein, provided compositions and methods are based on the development of certain compositions that include an influenza virus hemagglutinin antigen in combination with lipid vesicles that include a non-ionic surfactant (NISVs) and optionally an adjuvant. In certain embodiments, provided compositions remain potent even when they are not stored in a standard cold-chain system (i.e., they are thermostable).
